* Crown Electrokinetics Corp. CRKN.OQ CRKN.O is expected
to report results on March 30.
* Refinitiv's mean analyst estimate for Crown
Electrokinetics
Corp. is for a loss of 33 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Crown
Electrokinetics Corp. is $4.25, above its last closing price
of $1.67.
This summary was machine generated March 28 at 12:43 GMT. All
figures in US dollars unless otherwise stated